Enterobacterial infection modulates major histocompatibility complex class I expression on mononuclear cells

Immunology

Volumn 97, Issue 3, 1999, Pages 420-428

  Kirveskari, J ^a,b   He, Q ^a,b   Leirisalo Repo, M ^a,b   Maki Ikola O ^a,b   Wuorela, M ^a,b   Putto Laurila, A ^a,b   Granfors, Kaisa ^a,b,c  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; HLA B27 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; DOWN REGULATION; ENTEROBACTER INFECTION; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOMODULATION; KLEBSIELLA; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SALMONELLOSIS; SCHOOL CHILD; YERSINIOSIS;

ADOLESCENT; ADULT; ANTIGENS, SURFACE; ARTHRITIS, REACTIVE; DOWN-REGULATION; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A2 ANTIGEN; HLA-B27 ANTIGEN; HUMANS; KLEBSIELLA INFECTIONS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MONOCYTES; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 0032972893     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00803.x     Document Type: Article

References (28)

1. 1. GARRIDO F., RUIZ-CABELLO F., CABRERA T. et al. (1997) Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 18, 89.
2. 2. ANDERSSON M., PÄÄBO S., NILSSON T. et al. (1985) Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43, 215.
3. 3. HILL A.B., BARNETT B.C., MCMICHAEL A.J. et al. (1994) HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J Immunol 152, 2736.
4. 4. PLOEGH H.L. (1998) Viral strategies of immune evasion. Science 280, 248.
5. 5. SIEPER J. & BRAUN J. (1995) Pathogenesis of spondylarthropathies. Persistent antigen, autoimmunity, or both? Arthritis Rheum 38, 1547.
6. 6. FELTKAMP T.E.W., KHAN M.A. & LOPEZ DE CASTRO J.A. (1996) The pathogenetic role of HLA-B27. Immunol Today 17, 5.
7. 7. LÓPEZ DE CASTRO J.A. (1998) The pathogenetic role of HLA-B27 in chronic arthritis. Curr Opin Immunol 10, 59.
8. 8. KAPASI K. & INMAN R.D. (1992) HLA-B27 expression modulates Gram-negative bacterial invasion into transfected L cells. J Immunol 148, 3554.
9. 9. VlRTALA M., KIRVESKARI J. & GRANFORS K. (1997) HLA-B27 modulates the survival of Salmonella enteritidis in transfected L cells, possibly by impaired nitric oxide production. Infect Immun 65, 4236.
10. 10. LAITIO P., VIRTALA M., SALMI M. et al. (1997) HLA-B27 modulates intracellular survival of Salmonella enteritidis in human monocytic cells. Eur J Immunol 27, 1331.
11. 11. WUORELA M., JALKANEN S., KIRVESKARI J. et al. (1997) Yersinia enterocolitica serotype O: 3 alters the expression of serologie HLA-B27 epitopes on human monocytes. Infect Immun 65, 2060.
12. 12. REPO H., JÄÄTTELÄ M., LEIRISALO-REPO M. et al. (1988) Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis. Clin Exp Immunol 72, 410.
13. 13. PAZMANY L., ROWLAND-JONES S., HUET S. et al. (1992) Genetic modulation of antigen presentation by HLA-B27 molecules. J Exp Med 175, 361.
14. 14. IKAWA T., IKEDA M., YAMAGUCHI A. et al. (1998) Expression of arthritis-causing HLA-B27 on HeLa cells promotes induction of c-fos in response to in vitro invasion by Salmonella typhimurium. J Clin Invest 101, 263.
15. 15. YIN Z., BRAUN J., NEURE L. et al. (1997) Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum 40, 1788.
16. 16. ISOMÄKI O., VUENTO R. & GRANFORS K. (1989) Serological diagnosis of salmonella infections by enzyme immunoassay. Lancet i, 1411.
17. 17. KIRVESKARI J., JALKANEN S., MÄKI-IKOLA O. et al. (1998) Increased synovial endothelium binding and transendothelial migration of mononuclear cells during Salmonella infection. Arthritis Rheum 41, 1054.
18. IS. WUORELA M., JALKANEN S., TOIVANEN P. et al. (1993) Yersinia lipopolysaccharide is modified by human monocytes. Infect Immun 61, 5261.
19. 19. TANAKA J., IMAMURA M., KASAI M. et al. (1993) Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 85, 558.
20. 20. DOMINGUEZ O., COTO E., MARTINEZ-NAVES E. et al. (1992) Molecular typing of HLA-B27 alleles. Immunogenetics 36, 277.
21. 21. KIRVESKARI J., KELLNER H., WUORELA M. et al. (1997) False-negative serological HLA-B27 typing results may be due to altered antigenic epitopes and can be detected by polymerase chain reaction. Br J Rheumatol 36, 185.
22. 22. WANG J., YU D.T.Y., FUKAZAWA T. et al. (1994) A monoclonal antibody that recognizes HLA-B27 in the context of peptides. J Immunol 152, 1197.
23. 21. BOISGÉRAULT F., MOUNIER J., TIENG V. et al. (1998) Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shingella flexneri. Infect Immun 66, 4484.
24. 24. AMOR B., KAHAN A. & GEORGIADIS A.E. (1978) Transient loss of HLA B27, Lancet i, 284.
25. 25. NEUMULLER J., FISCHER M. & EBERL R. (1993) Failure of the serological determination of HLA-B27 due to antigen masking in patients with ankylosing spondylitis. Rheumatol Int 13, 163.
26. 26. UGRINOVIC S., MERTZ A., WU P. et al. (1997) A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis. J Immunol 159, 5715.
27. 27. ACKERMANN B., GOHLKE F., HERR W. et al. (1996) Quantification of TNF-α and IFN-γ producing Yersinia urease β-subunit specific CD8+ and CD4+ T cells using an ELISPOT assay a study in reactive arthritis. Arthritis Rheum 39, S163.
28. 28. KLEUNEN M.F., HUPPA J.B., LUCIN P. et al. (1997) A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J 16, 685.